Konstantin Masliantsev

6PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMolecular targetsGenome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 03, 2025
Hippo pathway effectors are associated with glioma patient survival, control cell proliferation and sterol metabolism through TEAD3.

Konstantin Masliantsev, Amandine Desette, Anne-Alicia Gonzalez

|Dec 10, 2021
MEOX2 Transcription Factor Is Involved in Survival and Adhesion of Glioma Stem-like Cells.

Gaëlle Tachon, Konstantin Masliantsev, Pierre Rivet

|Jan 22, 2021
Hippo Signaling Pathway in Gliomas.

Konstantin Masliantsev, Lucie Karayan-Tapon, Pierre-Olivier Guichet

|Jan 20, 2019
Prognostic significance of MEOX2 in gliomas.

Gaelle Tachon, Konstantin Masliantsev, Pierre Rivet

|Oct 05, 2018
Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51.

Gaelle Tachon, Ulrich Cortes, Pierre-Olivier Guichet

|Jul 17, 2018
Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence.

Pierre-Olivier Guichet, Konstantin Masliantsev, Gaëlle Tachon

Pageof 1